Prospective evaluation of the Supraflex™ sirolimus-eluting stent

• Research type

  Research Study

• Full title

  Prospective evaluation of the Supraflex™ sirolimus-eluting coronary stent system in a "real-world" patient population.

• IRAS ID

  171365

• Contact name

  Azfar Zaman

• Sponsor organisation

  Sahajanand Medical Technologies Pvt. Ltd (SMT)

• Duration of Study in the UK

  1 years, 9 months, 24 days

• Research summary

  The primary objective of this registry is to evaluate the safety and efficacy of the Supraflex™ sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.The study will be conducted on 500 patients, these patients must meet the criteria in order to take part in the study. All patients will be followed clinically at 12-months after the procedure has taken place.

• REC name

  Wales REC 7

• REC reference

  15/WA/0072

• Date of REC Opinion

  27 Feb 2015

• REC opinion

  Unfavourable Opinion